Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
Study Information
Alliance Study ID: NCCTG-98-81-52
NCT Study ID (ClinicalTrials.gov): NCT00005829
Disease or Cancer Type: Leukemia & Myelodysplastic Syndromes (MDS)
Alliance Study Chair: Timothy G. Call, MD
Status: COMPLETED
Study Description
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of gemcitabine in treating patients who have recurrent chronic lymphocytic leukemia.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information